Skip to main content
Baseline and Safety data from IASO, a pioneering open-label phase 1b trial assessing the safety, tolerability and gut microbiota analysis of an oral microbiotherapy in amyotrophic lateral sclerosis Dispose d’un menu contextuel Dispose d’un menu contextuel
Posters

Baseline and Safety data from IASO, a pioneering open-label phase 1b trial assessing the safety, tolerability and gut microbiota analysis of an oral microbiotherapy in amyotrophic lateral sclerosis Dispose d’un menu contextuel Dispose d’un menu contextuel

Date : 06/12/2024

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club